Evidence map›Paper›PMID 28828000›Full record

ArticleEXCLI journal2017

MicroRNA expression analysis in endometriotic serum treated mesenchymal stem cells.

Mazen Abdel-Rasheed, Ghada Nour Eldeen, Marwa Mahmoud, Mahmoud ElHefnawi, Nourhan Abu-Shahba, Mohamed Reda, Khaled Elsetohy, Michael Nabil, Amr Elnoury, Tamer Taha and 1 more

Open access · greenAbstract read
In one paragraph

Article in EXCLI journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Downregulation ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mazen Abdel-RasheedDepartment of Reproductive Health Research, National Research Centre, Cairo, Egypt.
Ghada Nour EldeenDepartment of Molecular Genetics and Enzymology, National Research Centre, Cairo, Egypt.
Marwa MahmoudDepartment of Medical Molecular Genetics, National Research Centre, Cairo, Egypt.
Mahmoud ElHefnawiBiomedical Informatics and Chemo-informatics group, Informatics and Systems Department, National Research Centre, Cairo, Egypt.
Nourhan Abu-ShahbaDepartment of Medical Molecular Genetics, National Research Centre, Cairo, Egypt.
Mohamed RedaDepartment of Reproductive Health Research, National Research Centre, Cairo, Egypt.
Khaled ElsetohyDepartment of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Michael NabilDepartment of Molecular Genetics, CliniLab, Cairo, Egypt.
Amr ElnouryDepartment of Medical Applications of Laser, National Institute of Laser Enhanced Sciences, Cairo University, Cairo, Egypt.
Tamer TahaDepartment of Reproductive Health Research, National Research Centre, Cairo, Egypt.
Osama AzmyDepartment of Reproductive Health Research, National Research Centre, Cairo, Egypt.
National Research Centre · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometriosis is defined by presence of endometrial-like-tissue outside the uterus. Recently, ectopic endometriotic lesions have been suggested to originate by abnormal differentiation of endometrial mesenchymal stem cells (eMSCs). MicroRNAs (miRNAs) play an important role in the pathophysiology of endometriosis. Through a PCR array approach, we aimed to assess the differential expression of microRNAs in human eMSC treated in culture with sera derived from women with severe endometriosis. Sera were collected from five patients with severe endometriosis and three control women and added individually in the culture medium to conduct experimental and control eMSC sets, respectively. Regular microscopic follow-up for cell morphology was performed. SYBR Green based real-time PCR array was used to assess the expression of 84 miRNAs. Bioinformatics analysis was done to predict the target genes of the significantly dysregulated miRNAs and their enriched biological processes and pathways. Thirty-two miRNAs were found significantly dysregulated in experimental cultures. Functional enrichment analysis revealed several endometriosis associated biological processes and pathways were enriched by target genes of these miRNAs. In conclusion, treatment of human eMSCs with sera of severe endometriosis cases affects the expression of certain miRNAs and their target genes. This may result in altering cell functions and consequently, endometriosis development.

Indexed as

differentiationendometriosismesenchymal stem cellsmiRNA expression

Identifiers

PMID28828000
PMCPMC5547388
OpenAlexW2770751966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.